Get the Stockscreener App
0.674
1.71%
0.0113
After Hours:
.65
-0.024
-3.56%
Envoy Medical Inc stock is traded at $0.674, with a volume of 99,922.
It is up +1.71% in the last 24 hours and up +1.13% over the past month.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
See More
Previous Close:
$0.6627
Open:
$0.6627
24h Volume:
99,922
Relative Volume:
0.27
Market Cap:
$51.91M
Revenue:
$234.00K
Net Income/Loss:
$-23.11M
P/E Ratio:
-0.6549
EPS:
-1.0292
Net Cash Flow:
$-20.71M
1W Performance:
+0.45%
1M Performance:
+1.13%
6M Performance:
+0.72%
1Y Performance:
-56.79%
1-Day Range:
$0.65
$0.70
1-Week Range:
$0.65
$0.7899
52-Week Range:
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
Name
Envoy Medical Inc
Sector
Industry
Phone
651-361-8000
Address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.674 | 51.04M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | H.C. Wainwright | Buy |
| Jun-24-24 | Initiated | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Stock (COCH) Latest News
Envoy Medical Inc (COCH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Capital Markets initiates Envoy Medical stock with buy rating By Investing.com - Investing.com Canada
Envoy Medical Inc (COCH) Cash Flow - TradingKey
Envoy Medical Inc (COCH) Income Statement - TradingKey
Envoy Medical Inc (COCH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Envoy Medical Inc (COCH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
COCH|Envoy Medical Inc|Price:0.663|Chg%:+0.002 - TradingKey
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant - Sahm
Exclusive: Envoy Medical builds momentum with improved cochlear implant trial results - MSN
Envoy Medical hits 3-month milestone in trial f... - Pluang
All 56 patients reach 3 months in Envoy Medical's hearing implant trial - Stock Titan
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. I - GuruFocus
Enterprise value to revenue forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN) - ACCESS Newswire
Enterprise value to EBIT forward of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical Inc Warrant (COCHW) Surges 36.7%: A Volatile Move Near Key LevelsATR Trailing Stop - dars.gov.et
Frontier tech research, news & data - MLQ.ai
H.C. Wainwright Maintains Envoy Medical(COCH.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Envoy Medical stock rating on trial progress - Investing.com
COCH Reiterated by HC Wainwright & Co. -- Price Target Maintained at $2.50 - GuruFocus
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results - Sahm
Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts - FinancialContent
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant - TMX Newsfile
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group - Newswire.com
Envoy Medical Inc (COCH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Envoy Medical (COCH) Rebounds Sharply: Key Levels and Technical OutlookCall Flow Alert - dars.gov.et
COCHEnvoy Medical Inc Earnings - Finviz
Envoy Medical, Inc. Warrant 2021-22.04.26 on Envoy Med-A Financial Disclosures & SEC Filings - TradingView
Insiders Of Envoy Medical Are Up 98% On Their US$8.17m Purchase - simplywall.st
Envoy Medical Ends ATM Equity Program Amid Capital Confidence - TipRanks
Envoy Medical Terminates At-The-Market Offering Agreement - TradingView
Envoy Medical (NASDAQ: COCH) terminates $15 million ATM equity facility - Stock Titan
Envoy Medical submits first module of PMA to FDA for implant - Investing.com South Africa
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device - TMX Newsfile
Envoy Medical starts FDA review of its breakthrough hearing device - Stock Titan
COCH Forecast — Price Target — Prediction for 2027 - TradingView
Envoy Medical, Inc. Class A Actuals & Estimates (BOATS:COCH) - TradingView
Envoy Medical boosts CEO Brent Lucas compensation with salary, bonus and equity awards - TradingView
Envoy Medical (NASDAQ: COCH) ties major CEO RSU grant to FDA approval - Stock Titan
Envoy Medical terminates $15 million equity offering facility - Investing.com
COCH: Fully implanted cochlear implant advances toward FDA approval, targeting a vast unmet market - TradingView
Envoy Medical Terminates At-the-Market (ATM) Equity Facility - TMX Newsfile
Envoy Medical terminates $15 million equity offering facility By Investing.com - Investing.com Canada
Envoy Medical shuts down its $15M stock-sale facility - Stock Titan
Form 4 Envoy Medical Inc For: 23 June By Investing.com - Investing.com Nigeria
Envoy Medical (COCH) CEO awarded 1M RSUs plus 1M options tied to FDA OK - Stock Titan
Number of shareholders of Envoy Medical, Inc. – NASDAQ:COCH - TradingView
Envoy Medical Inc (COCH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Envoy Medical Inc Stock (COCH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):